Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence H Price

Showing results (101-110 of 116) with videos related to

Pageof 12
Sort By:
Brain, Behavior, & Immunity - Health|September 27, 2022
Associations of circulating cell-free DNA, C-reactive protein, and cardiometabolic risk among low-active smokers with elevated depressive symptomsTeresa E Daniels, Emily K Zitkovsky, Zachary J Kunicki, et al.
The American Journal of Psychiatry|April 6, 2006
Elevated cerebrospinal fluid substance p concentrations in posttraumatic stress disorder and major depressionThomas D Geracioti, Linda L Carpenter, Michael J Owens, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|December 23, 2018
Development and Psychometric Evaluation of the Children's Yale-Brown Obsessive-Compulsive Scale Second EditionEric A Storch, Joseph F McGuire, Monica S Wu, et al.
Journal of Affective Disorders|November 17, 2019
Dose increase of S-Adenosyl-Methionine and escitalopram in a randomized clinical trial for major depressive disorderHitoshi Sakurai, Linda L Carpenter, Audrey R Tyrka, et al.
Psychopharmacology|June 29, 2010
Measuring smoking-related preoccupation and compulsive drive: evaluation of the obsessive compulsive smoking scaleBrian Hitsman, Biing-Jiun Shen, Ronald A Cohen, et al.
Experimental and Clinical Psychopharmacology|August 5, 2014
Effects of sequential fluoxetine and gender on prequit depressive symptoms, affect, craving, and quit day abstinence in smokers with elevated depressive symptoms: a growth curve modeling approachHaruka Minami, Christopher W Kahler, Erika Litvin Bloom, et al.
Biological Psychiatry|March 21, 2002
Genotype-controlled analysis of plasma dopamine beta-hydroxylase activity in psychotic unipolar major depressionJoseph F Cubells, Lawrence H Price, Barnett S Meyers, et al.
JAMA Psychiatry|May 5, 2021
Sustained Care Smoking Cessation Intervention for Individuals Hospitalized for Psychiatric Disorders: The Helping HAND 3 Randomized Clinical TrialRichard A Brown, Haruka Minami, Jacki Hecht, et al.
Psychosomatic Medicine|September 28, 2023
Circulating Cell-Free Mitochondrial DNA and Depressive Symptoms Among Low-Active Adults Who SmokeTeresa E Daniels, Emily K Zitkovsky, Laura E Laumann, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|May 21, 2009
A sequencing-based survey of functional APAF1 alleles in a large sample of individuals with affective illness and population controlsZenab Amin, Katarzyna Kanarek, Evgeny Krupitsky, et al.
Pageof 12

Showing results (101-110 of 116) with videos related to

Sort By:
Pageof 12
Brain, Behavior, & Immunity - Health|September 27, 2022
Associations of circulating cell-free DNA, C-reactive protein, and cardiometabolic risk among low-active smokers with elevated depressive symptomsTeresa E Daniels, Emily K Zitkovsky, Zachary J Kunicki, et al.
The American Journal of Psychiatry|April 6, 2006
Elevated cerebrospinal fluid substance p concentrations in posttraumatic stress disorder and major depressionThomas D Geracioti, Linda L Carpenter, Michael J Owens, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|December 23, 2018
Development and Psychometric Evaluation of the Children's Yale-Brown Obsessive-Compulsive Scale Second EditionEric A Storch, Joseph F McGuire, Monica S Wu, et al.
Journal of Affective Disorders|November 17, 2019
Dose increase of S-Adenosyl-Methionine and escitalopram in a randomized clinical trial for major depressive disorderHitoshi Sakurai, Linda L Carpenter, Audrey R Tyrka, et al.
Psychopharmacology|June 29, 2010
Measuring smoking-related preoccupation and compulsive drive: evaluation of the obsessive compulsive smoking scaleBrian Hitsman, Biing-Jiun Shen, Ronald A Cohen, et al.
Experimental and Clinical Psychopharmacology|August 5, 2014
Effects of sequential fluoxetine and gender on prequit depressive symptoms, affect, craving, and quit day abstinence in smokers with elevated depressive symptoms: a growth curve modeling approachHaruka Minami, Christopher W Kahler, Erika Litvin Bloom, et al.
Biological Psychiatry|March 21, 2002
Genotype-controlled analysis of plasma dopamine beta-hydroxylase activity in psychotic unipolar major depressionJoseph F Cubells, Lawrence H Price, Barnett S Meyers, et al.
JAMA Psychiatry|May 5, 2021
Sustained Care Smoking Cessation Intervention for Individuals Hospitalized for Psychiatric Disorders: The Helping HAND 3 Randomized Clinical TrialRichard A Brown, Haruka Minami, Jacki Hecht, et al.
Psychosomatic Medicine|September 28, 2023
Circulating Cell-Free Mitochondrial DNA and Depressive Symptoms Among Low-Active Adults Who SmokeTeresa E Daniels, Emily K Zitkovsky, Laura E Laumann, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|May 21, 2009
A sequencing-based survey of functional APAF1 alleles in a large sample of individuals with affective illness and population controlsZenab Amin, Katarzyna Kanarek, Evgeny Krupitsky, et al.
Pageof 12